Outcomes of high dose therapy and autologous haematopoietic stem cell transplantation for non‐hodgkin lymphoma: A retrospective analysis in a resource‐limited country-Reference-Cited by-同舟云学术

Outcomes of high dose therapy and autologous haematopoietic stem cell transplantation for non‐hodgkin lymphoma: A retrospective analysis in a resource‐limited country

Published:2020-11-28 Issue:3 Volume:75 Page:
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:Int J Clin Pract

Author:

Anuar Nur Adila¹^ORCID,Tey Kevin Wen Fei²^ORCID,Ng Soo Chin³,Teh Alan Kee Hean³^ORCID,Abdul Rahman Mohd Haris Fadzillah³,Chong Bee Ping¹^ORCID,Gan Gin Gin¹^ORCID

Affiliation:

1. Department of Medicine Universiti Malaya Kuala Lumpur Malaysia

2. Department of Pharmacology Universiti Malaya Kuala Lumpur Malaysia

3. Department of Haematology Subang Jaya Medical Centre Subang Jaya Malaysia

Publisher

Hindawi Limited

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijcp.13823

Reference47 articles.

1. StewartBW WildCP. World Cancer Report 2014. International Agency for Research on Cancer. Chapter 5.13. Haematopoietic and Lymphoid Malignancy;2014: 482‐486.

2. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001

3. Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

4. Past, Present, and Future of Rituximab—The World’s First Oncology Monoclonal Antibody Therapy

5. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-Hodgkin Lenfoma Olgularının Geriye Dönük Değerlendirilmesi: Tek Merkez Deneyimi;Van Sağlık Bilimleri Dergisi;2023-04-30

2. KIR genotype and haplotype frequencies in the multi-ethnic population of Malaysia;Human Immunology;2023-03

3. Efficacy and safety of autologous hematopoietic stem cell transplantation in the treatment of malignant lymphoma after chemotherapy: a systematic review and meta-analysis;Translational Cancer Research;2022-04